The company says it is known for its ‘unwavering commitment to enhancing patient lives through comprehensive testing services’ and that the investment is a strategic step in supporting key client programs.
The expansion includes the introduction of two Agilent 1260 Infinity II LCs – described as a robust high-performance liquid chromatography instrument offering a choice of modules for analytical HPLC and entry-level UHPLC.
High-performance liquid chromatography (HPLC), formerly referred to as high-pressure liquid chromatography, is a technique in analytical chemistry used to separate, identify, and quantify specific components in mixtures.
Enhancing chromatography
The company says the addition of the LCs complements its existing suite of high-performance liquid chromatography (HPLC) instruments, which includes the Thermo Ultimate 3000 UPLC and Waters Advance HPLC. This addition aligns with Cormica’s mission to offer unparalleled testing services that meet and exceed industry standards and client expectations.
In addition to enhancing our chromatography offerings, the company says it has also upgraded our particle size distribution (PSD) analysis capabilities with the Microtrac S3500 Laser Diffraction PSD Instrument, equipped with both wet and dry dispersers. This instrument joins our comprehensive array of particle size analyzers, including the MasterSizer and Sympatec instruments, offering our clients a broader choice and flexibility in PSD analysis.
Furthermore, the company says, the introduction of the Copley JVT100i Tapper Density Tester significantly advances its powder density testing capabilities. This equipment ensures that Cormica Bradford remains at the forefront of pharmaceutical and medical device testing, offering the most reliable and efficient services in the industry.
Caroline German, technical director at Cormica, said: “By expanding our equipment range and updating our capabilities, we’re not just enhancing our capacity; we’re aligning more closely with our clients’ hardware and methodologies.
“This streamlines the method development, validation, and transfer process, allowing for more efficient and seamless service delivery. At Cormica, we’re dedicated to maintaining the highest standards of quality and precision in all our testing services, and this investment is a testament to that commitment.”
German added that the enhancements at Cormica Bradford are aligned with the company’s global strategy to offer cutting-edge testing services that adhere to the highest industry certifications, including good manufacturing practice, good laboratory practice, and ISO 17025 accreditation.
ISO 17025 Accreditation proves a laboratory has an acceptable quality management system in place, and it has the ability and competence to provide testing and calibration results.
German said: “Cormica’s over 60 years of heritage in laboratory expertise, combined with its commitment to customer service, quality, and safety, ensures that it remains a trusted partner for medical device and pharmaceutical manufacturers worldwide.”
